Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free ELIX Stock Alerts

Elixirr International (ELIX) Stock Chart & Stock Price History

Elixirr International logo
GBX 706 +4.00 (+0.57%)
As of 11:02 AM Eastern
Compare

Elixirr International Stock Price Performance

The Elixirr International (ELIX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 16.94%, with a year-to-date return of -14.53%. In the past month, the stock has increased 0.86%, reflecting recent market activity.

As of the latest close, Elixirr International traded at GBX 700 with a market cap of £341.17 million and volume of 126,680 shares. Five years ago, the stock traded at GBX 510, representing a 38.43% increase over that period. At the time, it had a market cap of £235.55 million and a volume of 7,065 shares.

Receive ELIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elixirr International and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-0.84%
1 Month
Performance
+0.86%
3 Month
Performance
+3.08%
Year-To-Date
Performance
-14.53%
1 Year
Performance
-16.94%
5 Year
Performance
+38.43%

ELIX Stock Chart for Thursday, May, 14, 2026

ELIX Chart by TradingView

Elixirr International Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
05/13/2026GBX 704GBX 700
-0.57%		GBX 724GBX 692.50126,680 shs£341.17 million
05/12/2026GBX 716GBX 704
-1.68%		GBX 704GBX 690111,142 shs£343.12 million
05/11/2026GBX 712GBX 716
+0.56%		GBX 735.84GBX 700322,876 shs£348.97 million
05/08/2026GBX 712GBX 712GBX 720GBX 694207,685 shs£347.02 million
05/07/2026GBX 700GBX 712
+1.71%		GBX 720GBX 69684,746 shs£347.02 million
05/06/2026GBX 731.02GBX 700
-4.24%		GBX 721.84GBX 69245,426 shs£341.17 million
05/05/2026N/AGBX 731.02GBX 744GBX 69267,041 shs£356.29 million
04/30/2026GBX 750GBX 736
-1.87%		GBX 762GBX 73643,138 shs£358.72 million
04/29/2026GBX 780GBX 750
-3.85%		GBX 780GBX 7383.65 million shs£365.54 million
04/28/2026GBX 756.87GBX 780
+3.06%		GBX 780GBX 75085,144 shs£380.16 million
04/27/2026GBX 762.28GBX 756.87
-0.71%		GBX 780GBX 756125,711 shs£368.89 million
04/24/2026GBX 758GBX 762.28
+0.56%		GBX 768GBX 760189,784 shs£371.53 million
04/23/2026GBX 757.56GBX 758
+0.06%		GBX 767.84GBX 758123,340 shs£369.44 million
04/22/2026GBX 740GBX 757.56
+2.37%		GBX 766GBX 750117,820 shs£369.23 million
04/21/2026GBX 764GBX 740
-3.14%		GBX 770GBX 740184,647 shs£360.67 million
04/20/2026GBX 708GBX 764
+7.91%		GBX 764GBX 722.60155,794 shs£372.37 million
04/17/2026GBX 710GBX 708
-0.28%		GBX 730GBX 702104,301 shs£345.07 million
04/16/2026GBX 700GBX 710
+1.43%		GBX 730GBX 71065,141 shs£346.05 million
04/15/2026GBX 700.01GBX 700
0.00%		GBX 730GBX 70025,650 shs£341.17 million
04/14/2026GBX 700GBX 700.01
+0.00%		GBX 710GBX 69478,905 shs£341.18 million
04/13/2026GBX 698GBX 700
+0.29%		GBX 711.62GBX 678.7438,427 shs£341.17 million
Related Companies

This page (LON:ELIX) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Microscopic Footage Shows Immune Cells Attacking Cancer
Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using it...
Market Tactic | Sponsoredtc pixel
Read this or regret it forever
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
Millionaire warns: Move your money before May 15
Larry Benedict - the trader who generated $274 million in client profits and beat the S&P 500 by 18 times in 2...
Brownstone Research | Sponsoredtc pixel